EPHA3 and neoplasm: Furthermore, tumor growth was significantly decreased in TNBC transplanted in hIL-26Tg mice following administration of anti-EphA3 pAb and gefitinib (purple line in Fig. 6E), compared to that seen with control Ab and gefitinib (pale blue line in Fig. 6E).